S-23

Description

Blaze contains S-23, a potent investigational SARM studied for its impact on androgenic activity with high receptor binding affinity. It is of interest in androgen replacement and contraceptive research models.

laboratory

Vanguard Laboratory

Date of Analysis

28, JUNE 2025

Testing Type

Mass spectrometry is a high-tech tool used in labs to figure out what’s in a substance—like the stuff in SARMs. It works by breaking a sample into charged particles, sorting them by their weight, and identifying what each one is.
This helps scientists confirm the purity, potency, and exact makeup of the compounds you're putting in your body—ensuring you’re getting what the label says, nothing more, nothing less.

LABORATORY ANALYSIS OVERVIEW

Labeled Quantity

25 mg per capsule

Lab Result

Measured at 24.91 mg/CAP, indicating manufacturing consistency.

Testing Standard

Conducted using HPLC-UV/VIS to confirm purity and accurate dosing.

Retention Time

Primary peak observed at approx. 6.71 min, matching known reference points for S-23.

Documentation

Lot: 0089
Lab ID: V250611-16 008
Reported on: 06/28/2025

Accreditation & Scope

Results pertain only to submitted samples and are not a guarantee of entire batch uniformity. Use limited to controlled research environments.